Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 804

1.

Use of Scribes for Documentation Assistance in Rheumatology and Endocrinology Clinics: Impact on Clinic Workflow and Patient and Physician Satisfaction.

Danila MI, Melnick JA, Curtis JR, Menachemi N, Saag KG.

J Clin Rheumatol. 2018 Apr;24(3):116-121. doi: 10.1097/RHU.0000000000000620.

PMID:
29280815
2.

An ImmunoSignature test distinguishes Trypanosoma cruzi, hepatitis B, hepatitis C and West Nile virus seropositivity among asymptomatic blood donors.

Rowe M, Melnick J, Gerwien R, Legutki JB, Pfeilsticker J, Tarasow TM, Sykes KF.

PLoS Negl Trop Dis. 2017 Sep 5;11(9):e0005882. doi: 10.1371/journal.pntd.0005882. eCollection 2017 Sep. Erratum in: PLoS Negl Trop Dis. 2018 Feb 1;12 (2):e0006228.

3.

Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.

Wright NC, Foster PJ, Mudano AS, Melnick JA, Lewiecki EM, Shergy WJ, Curtis JR, Cutter GR, Danila MI, Kilgore ML, Lewis EC, Morgan SL, Redden DT, Warriner AH, Saag KG.

Osteoporos Int. 2017 Aug;28(8):2505. doi: 10.1007/s00198-017-4105-1. No abstract available.

PMID:
28593448
4.

Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.

Wright NC, Foster PJ, Mudano AS, Melnick JA, Lewiecki ME, Shergy WJ, Curtis JR, Cutter GR, Danila MI, Kilgore ML, Lewis EC, Morgan SL, Redden DT, Warriner AH, Saag KG.

Osteoporos Int. 2017 Aug;28(8):2495-2503. doi: 10.1007/s00198-017-4073-5. Epub 2017 May 24. Erratum in: Osteoporos Int. 2017 Jun 7;:.

5.

Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.

Sprague SM, Crawford PW, Melnick JZ, Strugnell SA, Ali S, Mangoo-Karim R, Lee S, Petkovich PM, Bishop CW.

Am J Nephrol. 2016;44(4):316-325. Epub 2016 Sep 28.

PMID:
27676085
6.

Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs.

Behrens CR, Ha EH, Chinn LL, Bowers S, Probst G, Fitch-Bruhns M, Monteon J, Valdiosera A, Bermudez A, Liao-Chan S, Wong T, Melnick J, Theunissen JW, Flory MR, Houser D, Venstrom K, Levashova Z, Sauer P, Migone TS, van der Horst EH, Halcomb RL, Jackson DY.

Mol Pharm. 2015 Nov 2;12(11):3986-98. doi: 10.1021/acs.molpharmaceut.5b00432. Epub 2015 Oct 2.

PMID:
26393951
7.

Fresh and cryopreserved ovary transplantation and resting follicle recruitment.

Silber S, Pineda J, Lenahan K, DeRosa M, Melnick J.

Reprod Biomed Online. 2015 Jun;30(6):643-50. doi: 10.1016/j.rbmo.2015.02.010. Epub 2015 Feb 27.

PMID:
25892498
8.

Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease.

Sprague SM, Silva AL, Al-Saghir F, Damle R, Tabash SP, Petkovich M, Messner EJ, White JA, Melnick JZ, Bishop CW.

Am J Nephrol. 2014;40(6):535-45. doi: 10.1159/000369939. Epub 2015 Jan 7.

9.

Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation.

Petkovich M, Melnick J, White J, Tabash S, Strugnell S, Bishop CW.

J Steroid Biochem Mol Biol. 2015 Apr;148:283-9. doi: 10.1016/j.jsbmb.2014.11.022. Epub 2014 Nov 22.

10.

Defining estrogenic mechanisms of bisphenol A analogs through high throughput microscopy-based contextual assays.

Stossi F, Bolt MJ, Ashcroft FJ, Lamerdin JE, Melnick JS, Powell RT, Dandekar RD, Mancini MG, Walker CL, Westwick JK, Mancini MA.

Chem Biol. 2014 Jun 19;21(6):743-53. doi: 10.1016/j.chembiol.2014.03.013. Epub 2014 May 22.

11.

Learning from health care workers' opinions for improving quality of neonatal health care in kilimanjaro region, northeast Tanzania.

Mbwele B, Ide N, Mrema J, Ward Sarah A, Melnick J, Manongi R.

Ann Med Health Sci Res. 2014 Jan;4(1):105-14. doi: 10.4103/2141-9248.126614.

12.

A mutation in TGFB3 associated with a syndrome of low muscle mass, growth retardation, distal arthrogryposis and clinical features overlapping with Marfan and Loeys-Dietz syndrome.

Rienhoff HY Jr, Yeo CY, Morissette R, Khrebtukova I, Melnick J, Luo S, Leng N, Kim YJ, Schroth G, Westwick J, Vogel H, McDonnell N, Hall JG, Whitman M.

Am J Med Genet A. 2013 Aug;161A(8):2040-6. doi: 10.1002/ajmg.a.36056. Epub 2013 Jul 3.

13.

Quality of neonatal healthcare in Kilimanjaro region, northeast Tanzania: learning from mothers' experiences.

Mbwele B, Ide NL, Reddy E, Ward SA, Melnick JA, Masokoto FA, Manongi R.

BMC Pediatr. 2013 May 3;13:68. doi: 10.1186/1471-2431-13-68.

14.

Synthesis, structure, and reactivity of two-coordinate mercury alkyl compounds with sulfur ligands: relevance to mercury detoxification.

Melnick JG, Yurkerwich K, Parkin G.

Inorg Chem. 2009 Jul 20;48(14):6763-72. doi: 10.1021/ic900721g.

15.

Decarbonylation of ethanol to methane, carbon monoxide and hydrogen by a [PNP]Ir complex.

Melnick JG, Radosevich AT, Villagrán D, Nocera DG.

Chem Commun (Camb). 2010 Jan 7;46(1):79-81. doi: 10.1039/b914083b. Epub 2009 Nov 23.

PMID:
20024299
16.

On the chalcogenophilicity of mercury: evidence for a strong Hg-Se bond in [Tm(Bu(t))]HgSePh and its relevance to the toxicity of mercury.

Melnick JG, Yurkerwich K, Parkin G.

J Am Chem Soc. 2010 Jan 20;132(2):647-55. doi: 10.1021/ja907523x.

17.

Ligand reactivity in diarylamido/bis(phosphine) PNP complexes of Mn(CO)3 and Re(CO)3.

Radosevich AT, Melnick JG, Stoian SA, Bacciu D, Chen CH, Foxman BM, Ozerov OV, Nocera DG.

Inorg Chem. 2009 Oct 5;48(19):9214-21. doi: 10.1021/ic9010218.

PMID:
19736909
18.

Monovalent indium in a sulfur-rich coordination environment: synthesis, structure and reactivity of tris(2-mercapto-1-tert-butylimidazolyl)hydroborato indium, [TmBut]In.

Yurkerwich K, Buccella D, Melnick JG, Parkin G.

Chem Commun (Camb). 2008 Jul 28;(28):3305-7. doi: 10.1039/b803037e. Epub 2008 Jun 2.

PMID:
18622452
19.

Pelvic ultrasound in acute appendicitis.

Melnick ER, Melnick JR, Nelson BP.

J Emerg Med. 2010 Feb;38(2):240-2. doi: 10.1016/j.jemermed.2007.09.054. Epub 2008 Jun 20. No abstract available.

PMID:
18571366
20.

Molecular structures of thimerosal (Merthiolate) and other arylthiolate mercury alkyl compounds.

Melnick JG, Yurkerwich K, Buccella D, Sattler W, Parkin G.

Inorg Chem. 2008 Jul 21;47(14):6421-6. doi: 10.1021/ic8005426. Epub 2008 Jun 6.

PMID:
18533648
21.

Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.

Ross EA, Tian J, Abboud H, Hippensteel R, Melnick JZ, Pradhan RS, Williams LA, Hamm LL, Sprague SM.

Am J Nephrol. 2008;28(1):97-106. Epub 2007 Oct 3.

PMID:
17914251
23.
24.

Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.

Greenbaum LA, Benador N, Goldstein SL, Paredes A, Melnick JZ, Mattingly S, Amdahl M, Williams LA, Salusky IB.

Am J Kidney Dis. 2007 Jun;49(6):814-23.

PMID:
17533024
25.

Vascular calcification in chronic kidney failure: role of vitamin D receptor.

Wu-Wong JR, Melnick J.

Curr Opin Investig Drugs. 2007 Mar;8(3):237-47. Review.

PMID:
17408120
26.

Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK.

Galkin AV, Melnick JS, Kim S, Hood TL, Li N, Li L, Xia G, Steensma R, Chopiuk G, Jiang J, Wan Y, Ding P, Liu Y, Sun F, Schultz PG, Gray NS, Warmuth M.

Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):270-5. Epub 2006 Dec 21. Erratum in: Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):2025.

27.

Health-economic comparison of paricalcitol, calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism during haemodialysis.

Rosery H, Bergemann R, Marx SE, Boehnke A, Melnick J, Sterz R, Williams L.

Clin Drug Investig. 2006;26(11):629-38. Review.

PMID:
17163297
28.

Synthesis and structural characterization of tris(2-seleno-1-mesitylimidazolyl) hydroborato complexes: a new type of strongly electron donating tripodal selenium ligand.

Minoura M, Landry VK, Melnick JG, Pang K, Marchi├▓ L, Parkin G.

Chem Commun (Camb). 2006 Oct 14;(38):3990-2. Epub 2006 Aug 10.

PMID:
17003875
31.

EPR spectroscopic and computational characterization of the hydroxyethylidene-thiamine pyrophosphate radical intermediate of pyruvate:ferredoxin oxidoreductase.

Mansoorabadi SO, Seravalli J, Furdui C, Krymov V, Gerfen GJ, Begley TP, Melnick J, Ragsdale SW, Reed GH.

Biochemistry. 2006 Jun 13;45(23):7122-31.

32.

A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4.

Abboud H, Coyne D, Smolenski O, Anger M, Lunde N, Qiu P, Hippensteel R, Pradhan RS, Palaparthy RV, Kavanaugh A, Melnick JZ, Williams LA, Batlle D.

Am J Nephrol. 2006;26(1):105-14. Epub 2006 Mar 14.

PMID:
16543714
34.

Thiolate exchange in [TmR]ZnSR' complexes and relevance to the mechanisms of thiolate alkylation reactions involving zinc enzymes and proteins.

Melnick JG, Zhu G, Buccella D, Parkin G.

J Inorg Biochem. 2006 May;100(5-6):1147-54. Epub 2006 Mar 6.

PMID:
16516971
35.

An efficient rapid system for profiling the cellular activities of molecular libraries.

Melnick JS, Janes J, Kim S, Chang JY, Sipes DG, Gunderson D, Jarnes L, Matzen JT, Garcia ME, Hood TL, Beigi R, Xia G, Harig RA, Asatryan H, Yan SF, Zhou Y, Gu XJ, Saadat A, Zhou V, King FJ, Shaw CM, Su AI, Downs R, Gray NS, Schultz PG, Warmuth M, Caldwell JS.

Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3153-8. Epub 2006 Feb 21.

36.

Effects of intravenous ABT-870 (iron (III)-hydroxide oligosaccharide) on mean arterial pressure and heart rate in the anaesthetized beagle: comparison with other iron-containing haematinic agents.

Preusser LC, Fryer RM, Gerhardt A, Hu Y, Delgado-Herrera L, Melnick JZ, Williams LA, Cox BF, Reinhart GA.

Clin Exp Pharmacol Physiol. 2005 Dec;32(12):1020-6.

PMID:
16445566
37.

Antiproteinuric effect of oral paricalcitol in chronic kidney disease.

Agarwal R, Acharya M, Tian J, Hippensteel RL, Melnick JZ, Qiu P, Williams L, Batlle D.

Kidney Int. 2005 Dec;68(6):2823-8.

38.

Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.

Greenbaum LA, Grenda R, Qiu P, Restaino I, Wojtak A, Paredes A, Benador N, Melnick JZ, Williams LA, Salusky IB.

Pediatr Nephrol. 2005 May;20(5):622-30. Epub 2005 Mar 23.

PMID:
15785941
40.

Identification of the two missing bacterial genes involved in thiamine salvage: thiamine pyrophosphokinase and thiamine kinase.

Melnick J, Lis E, Park JH, Kinsland C, Mori H, Baba T, Perkins J, Schyns G, Vassieva O, Osterman A, Begley TP.

J Bacteriol. 2004 Jun;186(11):3660-2.

41.

Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients.

Chen LC, Hao CY, Chiu YS, Wong P, Melnick JS, Brotman M, Moretto J, Mendes F, Smith AP, Bennington JL, Moore D, Lee NM.

Cancer Res. 2004 May 15;64(10):3694-700.

42.

Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings.

Dobrez DG, Mathes A, Amdahl M, Marx SE, Melnick JZ, Sprague SM.

Nephrol Dial Transplant. 2004 May;19(5):1174-81. Epub 2004 Mar 5.

PMID:
15004264
43.

An efficient enzymatic synthesis of thiamin pyrophosphate.

Melnick JS, Sprinz KI, Reddick JJ, Kinsland C, Begley TP.

Bioorg Med Chem Lett. 2003 Nov 17;13(22):4139-41.

PMID:
14592524
44.

Perfusion brain scintigraphy studies in infants and children with malformations of the vein of Galen.

Nass R, Kramer E, Molofsky W, Melnick J, de Hollisey M, Madrid M, Wisoff JH, Berenstein A.

Childs Nerv Syst. 2001 Sep;17(9):519-23.

PMID:
11585324
45.

The mechanism of action of bacimethrin, a naturally occurring thiamin antimetabolite.

Reddick JJ, Saha S, Lee J, Melnick JS, Perkins J, Begley TP.

Bioorg Med Chem Lett. 2001 Sep 3;11(17):2245-8.

PMID:
11527707
46.

Cytomegalovirus genome and the immediate-early antigen in cells of different layers of human aorta.

Pampou SYu, Gnedoy SN, Bystrevskaya VB, Smirnov VN, Chazov EI, Melnick JL, DeBakey ME.

Virchows Arch. 2000 Jun;436(6):539-52.

PMID:
10917167
47.

Frequency of coexistence of cytomegalovirus and Chlamydia pneumoniae in atherosclerotic plaques.

Qavi HB, Melnick JL, Adam E, Debakey ME.

Cent Eur J Public Health. 2000 May;8(2):71-3.

PMID:
10857040
48.

Role of citrate synthase in aldosterone-mediated sodium reabsorption.

Ullian ME, Robinson CJ, Evans CT, Melnick JZ, Fitzgibbon WR.

Hypertension. 2000 Apr;35(4):875-9.

49.

Renal citrate metabolism and urinary citrate excretion in the infant rat.

Melnick JZ, Preisig PA, Alpern RJ, Baum M.

Kidney Int. 2000 Mar;57(3):891-7.

50.

Converting enzyme inhibition causes hypocitraturia independent of acidosis or hypokalemia.

Melnick JZ, Preisig PA, Haynes S, Pak CY, Sakhaee K, Alpern RJ.

Kidney Int. 1998 Nov;54(5):1670-4.

Supplemental Content

Loading ...
Support Center